All Stories

  1. Sex Disparities in Ischemic Heart Disease Mortality Across United States: The Southern Burden of Excess Body Weight and Diet
  2. Changing clinical perspectives on sex and healthcare disparities in ischaemic heart disease
  3. Sex Disparities in Ischemic Heart Disease in South Asia
  4. Anticancer-Drug-Related Cardiotoxicity from Adjuvant Goserelin and Tamoxifen Therapy
  5. Sex Disparities in Ischemic Heart Disease Mortality in Europe
  6. Early coronary revascularization among ‘stable’ patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age
  7. The European Society of Cardiology Working Group on Coronary Pathophysiology and Microcirculation
  8. Announcing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular health
  9. Coronary revascularization and sex differences in cardiovascular mortality after myocardial infarction in 12 high and middle-income European countries
  10. Net adverse clinical events with P2Y12 inhibitor therapy in older patients after percutaneous coronary interventions
  11. Traditional risk factors and premature acute coronary syndromes in South Eastern Europe: a multinational cohort study
  12. Combined Therapy with Anthracyclines and GnRH Analogues for Breast Cancer: Impact on Ischemic Heart Disease
  13. Clinical determinants of ischemic heart disease in Eastern Europe
  14. The ESC Working Group on Coronary Pathophysiology and Microcirculation
  15. Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease
  16. Sex Differences in Heart Failure Following Acute Coronary Syndromes
  17. Sex differences and disparities in cardiovascular outcomes of COVID-19
  18. Micrornas As Potential Biomarkers In Coronary Artery Disease
  19. Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation
  20. The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease
  21. Statins for primary prevention among elderly men and women
  22. Gender Differences in Non-Obstructive Coronary Artery Disease
  23. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the Eu...
  24. Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation positio...
  25. Concerns about the use of digoxin in acute coronary syndromes
  26. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’
  27. Vasospastic Angina and its Relationship with the Coronary Microcirculation
  28. Coronary No-Reflow Phenomenon in Clinical Practice
  29. Short term outcomes in the elderly patients with non-ST-elevation acute coronary syndromes undergoing early percutaneous coronary intervention: a report from the ISACS-TC registry
  30. Female sex as a biological variable: A review on younger patients with acute coronary syndrome
  31. Sex Differences in Outcomes After STEMI
  32. Prognostic implications of peripheral artery disease in coronary artery disease
  33. OBSOLETE: STEMI: Diagnosis
  34. OBSOLETE: STEMI: Prognosis
  35. OBSOLETE: STEMI: Management
  36. STEMI: Diagnosis
  37. STEMI: Management
  38. STEMI: Prognosis
  39. Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide
  40. Acute Coronary Syndrome: The Risk to Young Women
  41. A Short History of Vasospastic Angina ∗
  42. Delayed Care and Mortality Among Women and Men With Myocardial Infarction
  43. Post cardiovascular surgery atrial fibrillation. Biomarkers determining prognosis.
  44. Position paper of the European Society of Cardiology–working group of coronary pathophysiology and microcirculation: obesity and heart disease
  45. ACUTE CORONARY SYNDROME: THE RISK TO BE YOUNG AND WOMEN
  46. Invasive versus conservative strategy in acute coronary syndromes: The paradox in women's outcomes
  47. Primary percutaneous coronary intervention in octogenarians
  48. The no-reflow phenomenon in the young and in the elderly
  49. Contemporary roles of registries in clinical cardiology: Insights from Western and Eastern European countries
  50. Association between comorbidities and absence of chest pain in acute coronary syndrome with in-hospital outcome
  51. Factors associated with use of percutaneous coronary intervention among elderly patients presenting with ST segment elevation acute myocardial infarction (STEMI): Results from the ISACS-TC registry
  52. Atypical Chest Pain in ACS: A Trap Especially for Women
  53. Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease
  54. Hypertension and Ischemic Heart Disease in Women
  55. Early Invasive Strategy for Unstable Angina: a New Meta-Analysis of Old Clinical Trials
  56. Big data: a new look at old problems
  57. DELAY TO HOSPITAL ADMISSION AND ACUTE CORONARY CARE IN THE ELDERLY AND IN THE VERY ELDERLY
  58. SEX-BASED DIFFERENCES IN SHORT TERM SURVIVAL AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION: THE ROLE OF SYSTEM DELAY
  59. Comparison of Early Versus Delayed Oral β Blockers in Acute Coronary Syndromes and Effect on Outcomes
  60. Persisting chest pain in nonobstructive coronary artery disease
  61. Reperfusion therapy for ST-elevation acute myocardial infarction in Eastern Europe: the ISACS-TC registry
  62. Unfractionated heparin–clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy
  63. Vasotonic Angina as a Cause of Myocardial Ischemia in Women
  64. SEX-RELATED DIFFERENCES IN ACUTE CORONARY CARE AMONG PATIENTS WITH MYOCARDIAL INFARCTION: THE ROLE OF PRE-HOSPITAL DELAY
  65. DETECTING ACUTE STRESS DISORDERS IN PATIENTS WITH CORONARY ARTERY DISEASE: A PROGNOSTIC EVALUATION OF THE PHQ-9 IN ACUTE CORONARY CARE: FINDINGS FROM THE ISACS-TC STUDY
  66. EARLY VERSUS DELAYED USE OF BETA-BLOCKERS IN ACUTE CORONARY SYNDROMES: A LANDMARK ANALYSIS. FROM THE ISACS-TC STUDY
  67. PARADOXICAL SEX DIFFERENCE IN IN-HOSPITAL OUTCOME FOLLOWING AN ACUTE CORONARY SYNDROME MANAGED CONSERVATIVELY: RESULTS FROM THE ISACS-TC
  68. Exploring In-hospital Death from Myocardial Infarction in Eastern Europe: From the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC); on the Behalf of the Working Group on Coronary Pathophysiology & Microcirculatio...
  69. Effects of Angiotensin-Converting Enzyme Inhibitors and Beta Blockers on Clinical Outcomes in Patients With and Without Coronary Artery Obstructions at Angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes)
  70. ROUTINE PERCUTANEOUS CORONARY INTERVENTION VERSUS MEDICAL THERAPY IN CLINICAL PRACTICE: THE ISACS-TC REGISTRY
  71. Acute coronary syndrome in octogenarian patients: results from the international registry of acute coronary syndromes in transitional countries (ISACS-TC) registry
  72. Clinical profile of patients with no-reperfusion therapy in Bosnia and Herzegovina and Serbia
  73. Gender differences in case fatality rates of acute myocardial infarction in Serbia
  74. Hypertension and acute coronary syndromes in Romania: data from the ISACS-TC registry
  75. Endothelial Dysfunction and Long-Term Prognosis of Variant Angina
  76. Endothelial dysfunction versus early atherosclerosis: A study with high resolution imaging
  77. Presentation, management and outcomes of ischaemic heart disease in women
  78. UNFRACTIONED HEPARIN/CLOPIDOGREL INTERACTION IN PATIENTS WITH STEMI NOT UNDERGOING REPERFUSION